Comparison of two automated nephelometers.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 1432366)

Published in J Clin Lab Anal on January 01, 1992

Authors

K Emancipator1, R J Elin, T A Fleisher

Author Affiliations

1: Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland.

Articles citing this

Comments on "Comparison of two automated nephelometers" by Emancipator et al. J Clin Lab Anal (1993) 0.75

Articles by these authors

(truncated to the top 100)

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med (1995) 6.77

Endotoxemia in human septic shock. Chest (1991) 3.52

Nonspecificity of the limulus amebocyte lysate test: positive reactions with polynucleotides and proteins. J Infect Dis (1973) 3.40

Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med (1990) 2.82

A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J Immunol (1981) 2.73

Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods (1995) 2.35

Preparation and properties of a national reference endotoxin. J Clin Microbiol (1976) 2.30

Interference with clinical laboratory analyses. Clin Chem (1994) 2.20

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood (2001) 2.15

Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum (1993) 2.14

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest (1992) 2.13

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood (1997) 2.10

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med (1994) 2.07

Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood (1990) 2.02

Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood (1995) 1.99

Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. J Clin Invest (1978) 1.90

Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest (1989) 1.87

Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood (1994) 1.79

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet (1999) 1.74

Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood (1997) 1.73

A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA (1993) 1.59

Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol (1998) 1.59

The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. J Infect Dis (1978) 1.59

Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood (1997) 1.58

The effect of alcohol withdrawal on serum concentrations of Lp(a), apolipoproteins A-1 and B, and lipids. Alcohol Clin Exp Res (1992) 1.57

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood (2001) 1.55

In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect Immun (1992) 1.52

Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc Natl Acad Sci U S A (1997) 1.48

Comparative analysis of whole blood lysis methods for flow cytometry. Cytometry (1997) 1.47

The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort. Transfusion (2010) 1.45

Biology of endotoxin. Annu Rev Med (1976) 1.44

A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis. Arthritis Rheum (1998) 1.43

Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood (2001) 1.42

Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol (1998) 1.41

Effect of induced fever on serum iron and ferritin concentrations in man. Blood (1977) 1.41

The role of iron in nonspecific resistance to infection induced by endotoxin. J Immunol (1974) 1.40

Increased peripheral T lymphocyte activation in patients with karyotypically normal spontaneous premature ovarian failure. Fertil Steril (1991) 1.39

The place of the computer in diagnostic medical bacteriology. Prog Clin Pathol (1978) 1.38

Thiocyanate in smokers interferes with the Nova magnesium ion-selective electrode. Clin Chem (1997) 1.38

Lack of clinical usefulness of the limulus test in the diagnosis of endotoxemia. N Engl J Med (1975) 1.36

Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency. J Infect Dis (1998) 1.35

Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation. J Immunol (1981) 1.34

Detection of endotoxin in cerebrospinal and joint fluids by limulus assay. Arch Intern Med (1977) 1.33

Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance. Clin Pharmacol Ther (1975) 1.32

Comparison of the pyrogenicity, Limulus activity mitogenicity and complement reactivity of several bacterial endotoxins and related compounds. J Immunol (1976) 1.31

Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans. J Infect Dis (1981) 1.27

Endotoxemia associated with the Jarisch-Herxheimer reaction. N Engl J Med (1976) 1.24

TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin Immunol (2001) 1.20

Vitamin A-induced nonspecific resistance to infection. J Infect Dis (1974) 1.20

Frequency analysis of IgE-secreting B lymphocytes in persons with normal or elevated serum IgE levels. J Immunol (1991) 1.19

Clinical utility of the Limulus amebocyte lysate (LAL) test. Prog Clin Biol Res (1985) 1.15

Infection and immunoglobulin concentrations in Chediak-Higashi mice. Infect Immun (1974) 1.15

Relationships between magnesium and protein concentrations in serum. Clin Chem (1985) 1.13

Effect of pH and iron concentration on growth of Candida albicans in human serum. J Infect Dis (1973) 1.11

IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J Immunol (2001) 1.11

Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin Immunol (2001) 1.10

T and B lymphocyte subpopulations in children. Pediatrics (1975) 1.09

Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac. Ann Neurol (1998) 1.08

Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals. Cytometry (1996) 1.08

Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): studies in humans and mice. Blood (1979) 1.08

IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes. J Rheumatol (1988) 1.08

Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr (1996) 1.07

X-linked hypogammaglobulinemia and isolated growth hormone deficiency. N Engl J Med (1980) 1.07

Unexpected and variable phenotypes in a family with JAK3 deficiency. Genes Immun (2001) 1.05

Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve (1997) 1.04

The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure. J Exp Med (1994) 1.04

Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival. Pediatr Clin North Am (2000) 1.03

Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood: impaired mobilization in chronic granulomatous disease and adenosine deaminase--deficient severe combined immunodeficiency disease patients. Blood (1996) 1.03

Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. Clin Chem (1994) 1.01

Mechanism of interference with the Jaffé reaction for creatinine. Clin Chem (1987) 1.01

N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med (1992) 1.01

The interference of T cell activation by calcium channel blocking agents. J Immunol (1984) 1.01

Intestinal lymphangiectasia, a disease characterized by selective loss of naive CD45RA+ lymphocytes into the gastrointestinal tract. Eur J Immunol (1998) 1.00

Nitroblue tetrazolium and Limulus assays for bacteremia after dental extraction: effect of topical antiseptics. J Am Dent Assoc (1978) 0.99

Antibiotics versus cardiovascular support in a canine model of human septic shock. Am J Physiol (1990) 0.99

Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. Chest (1990) 0.99

Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis. Am Rev Respir Dis (1991) 0.98

Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults. Blood (2000) 0.98

Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. II. Characterization of a soluble suppressor of B cell immunoglobulin production. J Immunol (1981) 0.97

Granulocyte transfusion therapy of experimental Pseudomonas pneumonia. J Clin Invest (1974) 0.97

The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma. Leuk Lymphoma (2001) 0.96

Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am J Pathol (2000) 0.96

Normalization of antibody responsiveness in a patient with common variable hypogammaglobulinemia and HIV infection. N Engl J Med (1987) 0.96

An evaluation of analytic goals for assays of drugs: a College of American Pathologists Therapeutic Drug Monitoring Survey Study. Arch Pathol Lab Med (2001) 0.93

Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis. Adv Exp Med Biol (1993) 0.92

Lack of specificity of the limulus lysate test in the diagnosis of pyogenic arthritis. J Infect Dis (1978) 0.92

Experimental Pseudomonas pneumonia in leukopenic dogs: comparison of therapy with antibiotics and granulocyte transfusions. Blood (1976) 0.92

Characterization of cross reactivity by carbamazepine 10,11-epoxide with carbamazepine assays. Clin Biochem (2001) 0.91

Physical and biological properties of U.S. standard endotoxin EC after exposure to ionizing radiation. Infect Immun (1983) 0.91

Management of neutralizing antibody to Ceredase in a patient with type 3 Gaucher disease. Pediatrics (1997) 0.91

Bronchoalveolar lavage analysis in Wegener's granulomatosis. A method to study disease pathogenesis. Am Rev Respir Dis (1991) 0.90

Hematopoiesis in the grey collie dog: studies of the regulation of erythropoiesis. J Clin Invest (1974) 0.90

Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock. J Pharmacol Exp Ther (1995) 0.89

Magnesium content of mononuclear blood cells. Clin Chem (1985) 0.89

Production of human suppressor T cell hybridomas. J Immunol (1982) 0.88

Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I. Am J Med (1991) 0.88

Corticosteroid-responsive intestinal lymphangiectasia secondary to an inflammatory process. N Engl J Med (1979) 0.88

A model for assessing interference. Clin Chem (1987) 0.88

Body fluid electrolyte composition of chronically magnesium-deficient and control rats. Am J Physiol (1971) 0.88

Incidence of gamma-globulin banding in a healthy population by high-resolution electrophoresis. Clin Chem (1982) 0.87